Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Antiretroviral Prophylaxis drugs are taken to prevent the spread of HIV. It is taken most often by HIV-positive mothers to prevent the transmission of the disease to her unborn child.
In a study conducted in 2012, a correlation was found between Antiretroviral Prophylaxis drugs and birth defects. The study was published in the Cleft-Palate Craniofacial Journal, and looked at evidence spanning over five years. In those years, there was a recorded 27 cases of cleft lip and cleft palate in children whose mother was taking the drug.
The study mentioned the drug Sustiva as having the highest rate of birth defects in its patients. Sustiva is classified as a non-nucleoside reverse transcriptase inhibitor (NNRTI), and has been used in combination with Combivir and Truvada. An early report on the drug revealed that it could potentially cause birth defects, but a report published in 2010 claimed that Sustiva did not, in fact, have that result. The 2012 study proved that the first research may have been the most accurate.
The following Antiretroviral Prophylaxis drugs have been found to cause birth defects:
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.